YOHANA SHUM: Open Payments
NPI 1265996532 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,167 in 120 payments from 19 companies in 2025. Trend: 2023 $2,077 · 2024 $2,205 · 2025 $4,167
Food & beverage: $4,068Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 19 | $658 |
| Incyte Corporation | 16 | $619 |
| Galderma Laboratories, L.P. | 19 | $462 |
| Regeneron Healthcare Solutions, Inc. | 7 | $404 |
| LEO Pharma Inc. | 9 | $388 |
| PFIZER INC. | 13 | $269 |
| UCB, Inc. | 5 | $230 |
| Janssen Biotech, Inc. | 9 | $182 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Madrigal Pharmaceuticals | 1 | $144 |
Products named: DUPIXENT, OPZELURA, NEMLUVIO, ANZUPGO, CIBINQO, Bimzelx, TREMFYA, IQIRVO.
Industry payments across NY — which companies pay providers there.
